In patients with common femoral artery disease, balloon angioplasty plus stenting if needed achieves acceptable restenosis and target lesion revascularization (TLR) rates at 1 year. The results render ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio LAS VEGAS — A repuncturable vascular ...
Patients with peripheral arterial disease experienced significantly improved quality of life when treated with the S.M.A.R.T. vascular stent system, according to data presented at VIVA 2013.
New Clinical Data Presented for First Time at Medical Meetings in U.S. and Europe Show Durable Vessel Patency in Treating Atherosclerotic Lesions of Superficial Femoral Artery MINNEAPOLIS –– ...
The FDA today approved Cook Medical's Zilver PTX stent. It is the first drug-eluting stent (DES) approved for the treatment of peripheral arterial disease (PAD) in the superficial femoral and proximal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results